TWC
XFOR icon

TD Waterhouse Canada’s X4 Pharmaceuticals XFOR Stock Holding History

TD Waterhouse Canada’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,500
Closed -$5.37K – 2178
2025
Q3 		$5.37K Hold
1,500
– – ﹤0.01% 1674
2025
Q2 		$2.81K Hold
1,500
– – ﹤0.01% 1697
2025
Q1 		$9.81K Hold
1,500
– – ﹤0.01% 1405
2024
Q4 		$33.5K Hold
1,500
– – ﹤0.01% 1171
2024
Q3 		$28.6K Buy
+1,500
New +$31.3K ﹤0.01% 1168

Other funds holding XFOR

EAM
Empery Asset Management New York $83M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

TD Waterhouse Canada's XFOR Position: Q4 2025 in Review

TD Waterhouse Canada sold out of X4 Pharmaceuticals (XFOR) in Q4 2025, closing a stake of 1,500 shares — an estimated $5.37K sold.

TD Waterhouse Canada first reported a position in XFOR in Q3 2024 and held it in 5 quarters. The position peaked at $33.5K in Q4 2024. 79 funds tracked by Wall St. Rank hold XFOR as of Q4 2025.

  • TD Waterhouse Canada reported no remaining X4 Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • TD Waterhouse Canada sold 1,500 X4 Pharmaceuticals shares in Q4 2025, an estimated $5.37K.
  • TD Waterhouse Canada first reported a position in X4 Pharmaceuticals in Q3 2024 and held it in 5 quarters.
  • TD Waterhouse Canada's X4 Pharmaceuticals position peaked at $33.5K in Q4 2024.
  • 79 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q4 2025.

Based on TD Waterhouse Canada's 13F filing for Q4 2025, filed 27 Jan 2026.